Free shipping on all orders over $ 500

Tuvusertib

Cat. No. M54526

All AbMole products are for research use only, cannot be used for human consumption.

Tuvusertib Structure
Synonym:

M1774; ATR inhibitor 1

Size Price Availability Quantity
5mg USD 170  USD170 In stock
10mg USD 270  USD270 In stock
25mg USD 500  USD500 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Tuvusertib is a selective and orally active ATR inhibitor that kills tumor cells by preventing the repair of damaged DNA with a Ki value below 1 μΜ.

Chemical Information
Molecular Weight 370.32
Formula C16H12F2N8O
CAS Number 1613200-51-3
Form Solid
Solubility (25°C) DMSO 5 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related ATM/ATR Products
KU-55933

KU-55933 is a cell-permeable ATP-competitive inhibitor of ATM (IC50 = 13 nM; Ki = 2.2 nM) with selectivity over other PIKK family kinases (IC50 = 2.5, 9.3, 16.6 μM for DNAPK, mTOR, PI 3-K, respectively; IC50 > 100 μM for PI 4-K and ATR).

KU-60019

KU-60019 is a potent ATM kinase inhibitor with IC50 of 6.3 nM.

VE-821

VE-821 is a highly selective and potent ATR inhibitor with IC50 of 26 nM.

ETP-46464

ETP-46464 is a potent inhibitor against mTOR, ATR, DNA-PK, PI 3-Kα and ATM with IC50 of 0.6, 14, 36, 170 and 545 nM, respectively.

CP-466722

Cp-466722 is a reversible ATM inhibitor with IC50 value of 4.1 μM, but has no effect on PI3K, PIKK family proteins.

  Catalog
Abmole Inhibitor Catalog




Keywords: Tuvusertib, M1774; ATR inhibitor 1 supplier, ATM/ATR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.